The purpose of this study is to find out about the safety and effectiveness of the study
drug, sirolimus, in patients with uveitis and to utilize the potential effectiveness of
sirolimus, and yet to avoid the potential complications of systemic use of the drug. In this
study, the investigators will administer sirolimus either around (subconjunctival injection)
or inside the eye (intravitreal injection). Local administration of sirolimus to the eye is
not expected to have effects on the rest of the body. Therefore, it may offer a safer way
than the current methods used to control the inflammation caused by non-infectious uveitis.